# FDA Inspection 1299452 - National Blood Testing Partners, Inc. - January 23, 2026

Source: https://www.keypedia.com/records/fda_inspections/national-blood-testing-partners-inc/1ac621da-60fc-4bd3-9cfb-19969b5c3b5f
Source feed: FDA_Inspections

> FDA Inspection 1299452 for National Blood Testing Partners, Inc. on January 23, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1299452
- Company Name: National Blood Testing Partners, Inc.
- Inspection Date: 2026-01-23
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Atlanta District Office

## Related Documents

- [FDA Inspection 1299452 - 2026-01-23](https://www.keypedia.com/records/fda_inspections/national-blood-testing-partners-inc/79ec32ee-4b88-4b2d-9ba1-20953c666cc6)
- [FDA Inspection 1203577 - 2023-03-30](https://www.keypedia.com/records/fda_inspections/national-blood-testing-partners-inc/92fc2734-3cd7-4637-b743-7e9351ba7896)
- [FDA Inspection 1203577 - 2023-03-30](https://www.keypedia.com/records/fda_inspections/national-blood-testing-partners-inc/2458daca-d396-4bba-95c3-bde91d9a4108)

Company: https://www.keypedia.com/companies/national-blood-testing-partners-inc/d604705c-14ae-489b-8ae2-8d2fd403d407

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7